Generate a tailored SOP for Dr. Michael Seckl. Improve your application with a focused, well-structured draft.
Michael Seckl trained in medicine at University College London and University College Hospital, obtaining his BSc in Immunology in 1983 and his MBBS in 1986. He entered specialist training in Medical Oncology from 1989 to 1995, during which he spent three years at the Imperial Cancer Research Fund. He was awarded his PhD in 1995 from the University of London. Seckl became a Senior Lecturer at Imperial College while working as a post-doctoral fellow, enabling a series of successful grant applications to support his work in lung cancer. He was appointed as a Reader in 2000 and became a Professor in 2002. He currently heads the Molecular Oncology research team associated with lung cancer and serves as the Director of Post Graduate Studies for the Department of Surgery and Cancer at Imperial College. He is also the Director of the Charing Cross/Imperial College Trophoblastic Disease Centre, focusing on malignant ovarian germ cell tumours, and has established a supraregional tumour marker assay service. An international leader in trophoblastic disease, Seckl has been involved in multiple committees and editorial boards, contributing to cancer research with a focus on translational lung cancer biology and gestational trophoblastic disease. His work is widely recognized and supported by major funding bodies.
Imperial College London • London, England
Head of Molecular Oncology, leading research in lung cancer and gestational trophoblastic disease.
Specialisms available in Materials for the Energy Transition or Theory and Simulation of Materials.